Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10011381 | 0.86 | ALDH1A1 (0.60) | ALDH1A1CYP3A4TDP1CTRCMAPK1 | |
| SCHEMBL20011507 | 0.83 | ALDH1A1 (0.69) | ALDH1A1CYP3A4TDP1TP53MAPK1 | |
| Hydrochloric Acid SCHEMBL20240309 | 0.83 | ALDH1A1 (0.56) | ALDH1A1CYP3A4TDP1CTRCMAPK1 | |
| SCHEMBL1687651 | 0.83 | ACHE (0.50) | ALDH1A1TDP1HSD17B10 | |
| SCHEMBL24440494 | 0.83 | ESR1 (0.36) | ESR1 | |
| SCHEMBL23315135 | 0.83 | ESR1 (0.36) | ESR1 | |
| SCHEMBL13625949 | 0.83 | METAP2 (0.34) | — | |
| SCHEMBL24900396 | 0.83 | ESR1 (0.69) | ALDH1A1ESR1CYP3A4TP53ESR2 | |
| SCHEMBL23315174 | 0.78 | — | — | |
| SCHEMBL12990793 | 0.78 | HRH3 (0.39) | HRH3TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024002875-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING HALOGEN-FREE VIRGIN THERMOPLASTICS, STABILIZER COMPOSITION, MASTER BATCH OR CONCENTRATE, STABILIZED PLASTIC COMPOSITION, PROCESS FOR STABILIZING HALOGEN-FREE VIRGIN THERMOPLASTICS, AND USE OF COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-04 | — | — | WO | disclosed |
| EP-3980510-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023208801-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-11-02 | — | — | WO | disclosed |
| EP-3947540-B1 | METHOD FOR STABILIZING THERMOPLASTIC RECYCLATES, STABILIZED PLASTIC COMPOSITIONS, AND MOLDING COMPOUNDS AND MOLDED PARTS PRODUCED THEREFROM | FRAUNHOFER GES FORSCHUNG (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-4056667-B1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-08-02 | — | — | EP | disclosed |
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| EP-4194529-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| WO-2023066953-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-04-27 | — | — | WO | disclosed |
| US-20230068853-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2023-03-02 | — | — | US | disclosed |
| WO-2022122780-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2022-06-16 | — | — | WO | disclosed |
| US-20080293856-A1 | Stabilized polyolefin compositions | POLNOX CORPORATION | 2008-11-27 | — | — | US | disclosed |
| US-20070257234-A1 | Stabilization of Organic Materials | CIBA CORPORATION | 2007-11-08 | — | — | US | disclosed |
| US-7291662-B2 | Nonylcyclohexylphosphite ester polyolefin stabilizers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-11-06 | — | — | US | disclosed |
| US-7291669-B2 | Stabilized polyolefin compositions | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-11-06 | — | — | US | disclosed |
| US-20070225395-A1 | Thermally stable cationic photocurable compositions | WOLF JEAN-PIERRE | 2007-09-27 | — | — | US | disclosed |
| US-20070197697-A1 | Stabilized polyolefin compositions | BOTKIN JAMES H | 2007-08-23 | — | — | US | disclosed |
| US-20070149660-A1 | Stabilized polyolefin compositions | POLNOX CORPORATION | 2007-06-28 | — | — | US | disclosed |
| WO-2007050991-A1 | STABILIZED POLYOLEFIN COMPOSITIONS | POLNOX CORPORATION (US) | 2007-05-03 | — | — | WO | disclosed |
| US-20070088108-A1 | Stabilization of polyolefins with liquid cyclic phosphites | CIBA SPECIALTY CHEMICALS CORP. | 2007-04-19 | — | — | US | disclosed |
| US-20070021537-A1 | Stabilization of polyolefins with liquid tris-(mono-alkyl)phenyl phosphites | CIBA SPECIALTY CHEMICALS CORP. | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230068853-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | CXCR1, PYM1, F11 | ALDH1A1 2963/4885ESR1 1599/4885CYP3A4 1706/4885 |
| US-20070257234-A1 | Stabilization of Organic Materials | LPO, SOD1, GPX1 | ALDH1A1 6/4885ESR1 892/4885CYP3A4 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.